✦ LIBER ✦

Omitting axillary lymph node dissection in sentinel node negative breast cancer patients is safe: A long term follow-up analysis

✍ Scribed by Hans Torrenga; Hans Fabry; Joost R.M. van der Sijp; Paul J. van Diest; Rik Pijpers; Sybren Meijer

Publisher: John Wiley and Sons
Year: 2004
Tongue: English
Weight: 71 KB
Volume: 88
Category: Article
ISSN: 0022-4790
DOI: 10.1002/jso.20101

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Follow-up of sentinel node negative brea

Follow-up of sentinel node negative breast cancer patients without axillary lymph node dissection

✍ Peter Schrenk; Margit Hatzl-Griesenhofer; Andreas Shamiyeh; Wolfgang Waynad 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB

## Abstract ## Background The purpose of this study was to evaluate the feasibility of sentinel lymph node biopsy in breast cancer patients at our institution and to report the follow‐up status of node‐negative patients with removal of only the sentinel node. ## Methods A total of 247 breast can

Impact of axillary lymph node dissection

Impact of axillary lymph node dissection on breast cancer outcome in clinically node negative patients : A Systematic Review and Meta-Analysis

✍ Mona Sanghani; Ethan M. Balk; Blake Cady 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 336 KB 👁 2 views

## Abstract ## BACKGROUND: The regional lymph node control and survival impact of axillary dissection in breast cancer has been the subject of multiple randomized trials, with various results. This study reviews and conducts a meta‐analysis of contemporary trials of axillary dissection in patients

The prognostic value of p53 and c-erb b-

The prognostic value of p53 and c-erb b-2 immunostaining is overrated for patients with lymph node negative breast carcinoma : A multivariate analysis of prognostic factors in 613 patients with a follow-up of 14–30 years

✍ Wenche Reed; Einar Hannisdal; Per Johannes Boehler; Stein Gundersen; Herman Host 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 105 KB 👁 2 views

## BACKGROUND. Approximately 30% of breast carcinoma patients with negative lymph nodes die of their disease. Biologic markers such p53 protein and c-erb B-2 have been related to tumor progression, but their prognostic value remains controversial. ## METHODS. Two large series of a total of 613 ly